Evidence map›Paper›PMID 35791764›Full record

ArticleThe British journal of dermatology2022

Large-cell transformation is an independent poor prognostic factor in Sézary syndrome: analysis of 117 cases.

Christophe Bontoux, Adèle de Masson, Nicolas Thonnart, Caroline Ram-Wolff, Flavien Caraguel, Luciana Batista, Sabrina Carpentier, Hélène Moins-Teisserenc, Jacqueline Rivet, Marie-Dominique Vignon-Pennamen and 3 more

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Christophe BontouxDepartment of Pathology, Hôpital Saint-Louis, AP-HP, Paris, France.ORCID 0000-0001-5446-6197
Adèle de MassonDepartment of Dermatology, Hôpital Saint-Louis, AP-HP, Paris, France.ORCID 0000-0001-7828-6211
Nicolas ThonnartINSERM U976, HIPI, Paris, France.
Caroline Ram-WolffDepartment of Dermatology, Hôpital Saint-Louis, AP-HP, Paris, France.
Flavien CaraguelInnate Pharma, Marseille, France.
Luciana BatistaInnate Pharma, Marseille, France.
Sabrina CarpentierInnate Pharma, Marseille, France.
Hélène Moins-TeisserencUniversité de Paris, Institut de Recherche Saint-Louis, Paris, France.
Jacqueline RivetDepartment of Pathology, Hôpital Saint-Louis, AP-HP, Paris, France.
Marie-Dominique Vignon-PennamenDepartment of Pathology, Hôpital Saint-Louis, AP-HP, Paris, France.
Anne Marie-CardineINSERM U976, HIPI, Paris, France.
Martine BagotDepartment of Dermatology, Hôpital Saint-Louis, AP-HP, Paris, France.ORCID 0000-0002-1631-5192
Maxime BattistellaDepartment of Pathology, Hôpital Saint-Louis, AP-HP, Paris, France.ORCID 0000-0002-7053-7431
University of London Institute in Paris · FRInnate Pharma (France) · FRAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycosis FungoidesSezary SyndromeSkin NeoplasmsCell Transformation, NeoplasticHumansPrognosis

Identifiers

PMID35791764
PMCPMC9805072
OpenAlexW4283836876

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.